Keros Therapeutics, Inc. (KROS) vs Profound Medical Corp. (PROF)
A side-by-side comparison of Keros Therapeutics, Inc. and Profound Medical Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KROS
Keros Therapeutics, Inc.
$11.28HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
PROF
Profound Medical Corp.
$6.30HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
Total return — KROS vs PROF
growth of $100 · dividends reinvested · last 6yKROS -42.6% (-8.8%/yr)PROF -43.5% (-9.1%/yr)KROS compounded faster over this window
KROS PROF
KROS vs PROF: by the numbers
- •PROF is the larger company ($229M vs $224M market cap).
- •Both run net losses; PROF's is the smaller (-171.72% vs -553.88% net margin).
- •KROS grew revenue faster over the past five years (172.50% vs 16.55% CAGR).
Metrics side by side
Valuation
| Metric | KROS | PROF |
|---|---|---|
| P/S ratio | 14.89 | 12.04 |
| P/B ratio | 0.85 | 4.60 |
Profitability
| Metric | KROS | PROF |
|---|---|---|
| Gross margin | 94.68% | 71.79% |
| Operating margin | 28.94% | -256.27% |
| Net margin | -553.88% | -171.72% |
| ROE | -31.70% | -65.59% |
| ROIC | -36.49% | -61.03% |
Growth (annualized)
| Metric | KROS | PROF |
|---|---|---|
| Revenue CAGR (5Y) | 172.50% | 16.55% |
| Total return CAGR (5Y) | -21.98% | -15.23% |
Frequently asked
- Which has grown faster, KROS or PROF?
- Over the past five years, KROS grew revenue faster — KROS at a 172.50% CAGR versus PROF at 16.55%.
- How have KROS and PROF total returns compared?
- Over the past 5 years, KROS delivered -21.98% and PROF delivered -15.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Keros Therapeutics ROEProfound Medical ROEKeros Therapeutics operating marginProfound Medical operating marginKeros Therapeutics revenue growthProfound Medical revenue growthKeros Therapeutics free cash flowProfound Medical free cash flow
Keros Therapeutics & Profound Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.